Skip to main content
Top
Published in: Clinical & Experimental Metastasis 8/1999

01-08-1999

hMSH6 deficiency and inactivation of the αE-catenin invasion-suppressor gene in HCT-8 colon cancer cells

Authors: Stefan J. Vermeulen, Philip R. Debruyne, Giancarlo Marra, Frank P. Speleman, Petra Boukamp, Josef Jiricny, Andrew P. Cuthbert, Robert F. Newbold, Friedel H. Nollet, Frans M. van Roy, Marc M. Mareel

Published in: Clinical & Experimental Metastasis | Issue 8/1999

Login to get access
Metadata
Title
hMSH6 deficiency and inactivation of the αE-catenin invasion-suppressor gene in HCT-8 colon cancer cells
Authors
Stefan J. Vermeulen
Philip R. Debruyne
Giancarlo Marra
Frank P. Speleman
Petra Boukamp
Josef Jiricny
Andrew P. Cuthbert
Robert F. Newbold
Friedel H. Nollet
Frans M. van Roy
Marc M. Mareel
Publication date
01-08-1999
Publisher
Kluwer Academic Publishers
Published in
Clinical & Experimental Metastasis / Issue 8/1999
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI
https://doi.org/10.1023/A:1006724300022

Other articles of this Issue 8/1999

Clinical & Experimental Metastasis 8/1999 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine